Cycled light in the intensive care unit for preterm and low birth weight infants

Iris Morag1, Arne Ohlsson

  • 1The Edmond & Lily Safra Children's Hospital Sheba Medical Center, Tel Hashomer, Israel.

Insights

Cycled lighting (CL) may improve outcomes for preterm infants, showing trends toward better growth and shorter hospital stays compared to near darkness (ND) or continuous bright light (CBL). Further research is recommended to confirm these findings.

Area of Science:

  • Neonatal care
  • Developmental pediatrics
  • Clinical lighting interventions

Background:

  • The impact of different lighting conditions in neonatal intensive care units (NICUs) on infant development and health outcomes remains largely unquantified.
  • Optimizing the NICU environment is crucial for the well-being and growth of vulnerable preterm infants.

Purpose of the Study:

  • To systematically evaluate the effectiveness of cycled lighting (CL) compared to near darkness (ND) and continuous bright light (CBL) on the growth of preterm infants.
  • To assess the influence of different lighting regimens on key developmental and clinical outcomes in preterm infants at three and six months of age.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (CENTRAL, MEDLINE, EMBASE, CINAHL) and clinical trial registries up to May 2013.
  • Included randomized or quasi-randomized trials comparing cycled lighting (CL) with near darkness (ND) or continuous bright light (CBL) in preterm and low birth weight infants.
  • Data collection and analysis followed the established methodologies of the Cochrane Neonatal Review Group.

Main Results:

  • Six studies involving 424 infants compared CL with ND. While no significant differences in weight at 3 or 6 months were found, CL showed trends favoring improved day-night activity ratios and reduced crying.
  • CL was associated with a significant reduction in length of hospital stay (13 days shorter) compared to ND.
  • Two studies (82 infants) compared CL with CBL. CL showed trends towards higher mean weight at 3 months, fewer awake hours, shorter ventilator time, and earlier first oral feeding.
  • No safety concerns were identified across the included studies.

Conclusions:

  • Trends across multiple outcomes favored cycled lighting (CL) when compared to both near darkness (ND) and continuous bright light (CBL) for preterm infants.
  • The observed trends suggest potential benefits of CL, although statistical significance was not always achieved, possibly due to limited sample sizes.
  • Future research should prioritize well-powered trials comparing CL to ND to further elucidate its effects on preterm infant outcomes.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...